National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of the Oxford/AstraZeneca COVID-19 vaccine in Nigeria.
The Director-General of NAFDAC, Dr. Mojisola Adeyeye made the announcement during a live briefing on Thursday.
She said that the vaccine can be stored at 2 to 8-degree centigrade.
According to her, there are three additional vaccines undergoing evaluation, but evaluation on Astrazeneca shows that the vaccine is effective against the UK variant of the virus which has been reported in Nigeria.
Dr Adeyeye explained that the South African variant had not been reported in Nigeria, adding that the agency has over 30 herbal medicine undergoing review for listing.
The vaccine was recently approved by the W.H.O for emergency use, in a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and it’s committee went to work immediately to evaluate its safety and efficacy for Nigerians.